BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL) (original) (raw)
References
Janossy G, Bollum FJ, Bradstock KF, Ashley J . Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations Blood 1980 56: 430–441 CASPubMed Google Scholar
van Dongen JJ, Krissansen GW, Wolvers-Tettero IL, Comans-Bitter WM, Adriaansen HJ, Hooijkaas H, van Wering ER, Terhorst C . Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies Blood 1988 71: 603–612 CASPubMed Google Scholar
Ludwig WD, Harbott J, Bartram CR, Komischke B, Sperling C, Teichmann JV, Seibt-Jung H, Notter M, Odenwald E, Nehmer A . Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86 Rec Res Cancer Res 1993 131: 269–282 ArticleCAS Google Scholar
van Dongen JJ, Adriaansen HJ . Immunobiology of leukemia. In: Henderson ES, Lister TA, Greaves MF (eds) Leukemia6th edn: WB Saunders: Philadelphia 1996 pp 83–130 Google Scholar
Campana D, Coustan-Smith E, Behm FG . The definition of remission in acute leukemia with immunologic techniques Bone Marrow Transplant 1991 8: 429–437 CASPubMed Google Scholar
van Dongen JJ, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H . Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction Leukemia 1992 6: (Suppl. 1) 47–59 PubMed Google Scholar
Drach J, Drach D, Glassl H, Gattringer C, Huber H . Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease Cytometry 1992 13: 893–901 ArticleCAS Google Scholar
Campana D, Pui CH . Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance (see comments) Blood 1995 85: 1416–1434 CASPubMed Google Scholar
Orfao A, Ciudad J, Lopez-Berges MC, Lopez A, Vidriales B, Caballero MD, Valverde B, Gonzalez M, San Miguel JF . Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry Leuk Lymphoma 1994 13: (Suppl 1) 87–90 Article Google Scholar
van Dongen JJ, Szczepanski T, de Bruijn MA, van den Beemd MW, de Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJ, van Gastel-Mol EJ, Groeneveld K, Hooijkaas H . Detection of minimal residual disease in acute leukemia patients Cytok Mol Ther 1996 2: 121–133 CAS Google Scholar
Ciudad J, San Miguel JF, Lopez-Berges MC, Vidriales B, Valverde B, Ocqueteau M, Mateos G, Caballero MD, Hernandez J, Moro MJ, Mateos MV, Orfao A . Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia J Clin Oncol 1998 16: 3774–3781 ArticleCAS Google Scholar
Lucio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, Janossy G, van Dongen JJ, San Miguel JF . Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL Leukemia 1999 13: 419–427 ArticleCAS Google Scholar
Weir EG, Cowan K, LeBeau P, Borowitz MJ . A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection Leukemia 1999 13: 558–567 ArticleCAS Google Scholar
van Lochem EG, Groeneveld K, te Marvelde JG, van den Beemd MW, Hooijkaas H, van Dongen JJ . Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes: testing of a new fixation-permeabilization solution (letter) Leukemia 1997 11: 2208–2210 ArticleCAS Google Scholar
Groeneveld K, te Marvelde JG, van den Beemd MW, Hooijkaas H, van Dongen JJ . Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes Leukemia 1996 10: 1383–1389 CASPubMed Google Scholar
Barcena A, Muench MO, Roncarolo MG, Spits H . Tracing the expression of CD7 and other antigens during T and myeloid cell differentiation in the human fetal liver and thymus Leuk Lymphoma 1995 17: 1–11 ArticleCAS Google Scholar
Barcena A, Galy AH, Punnonen J, Muench MO, Schols D, Roncarolo MG, de Vries JE, Spits H . Lymphoid and myeloid differentiation of fetal liver CD34+ linkeage− cells in human thymic organ culture J Exp Med 1994 180: 123–132 ArticleCAS Google Scholar
Schmitt C, Ktorza S, Sarun S, Verpilleux MP, Blanc C, Deugnier MA, Dalloul A, Debre P . CD34-positive early stages of human T-cell differentiation Leuk Lymphoma 1995 17: 43–50 ArticleCAS Google Scholar
Res P, Martinez-Caceres E, Cristina JA, Staal F, Noteboom E, Weijer K, Spits H . CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells Blood 1996 87: 5196–5206 CASPubMed Google Scholar
Spits H, Blom B, Jaleco AC, Weijer K, Verschuren MC, van Dongen JJ, Heemskerk MH, Res PC . Early stages in the development of human T, natural killer and thymic dendritic cells Immunol Rev 1998 165: 75–86 ArticleCAS Google Scholar
Blom B, Res P, Noteboom E, Weijer K, Spits H . Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage J Immunol 1997 158: 3571–3577 CASPubMed Google Scholar
Lazarovits AI, Osman N, Le Feuvre CE, Ley SC, Crumpton MJ . CD7 is associated with CD3 and CD45 on human T cells J Immunol 1994 153: 3956–3966 CASPubMed Google Scholar
Ginaldi L, Farahat N, Matutes E, De Martinis M, Morilla R, Catovsky D . Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry J Clin Pathol 1996 49: 539–544 ArticleCAS Google Scholar
van Wering ER, Beishuizen A, Roeffen ET, van der Linden-Schrever BE, Verhoeven MA, Hahlen K, Hooijkas H, van Dongen JJ . Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia Leukemia 1995 9: 1523–1533 CASPubMed Google Scholar
van Dongen JJ, Hooijkaas H, Comans-Bitter M, Hahlen K, de Klein A, van Zanen GE, van't Veer MB, Abels J, Benner R . Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes J Immunol 1985 135: 3144–3150 CASPubMed Google Scholar
Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, Stewart CC, To LB . Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry Blood 1991 77: 2591–2596 CASPubMed Google Scholar
Long H, Gaffney P, Mortari F, Miller JS . CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression Exp Hematol 1996 24: 1402–1408 CASPubMed Google Scholar
Campana D, Thompson JS, Amlot P, Brown S, Janossy G . The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage J Immunol 1987 138: 648–655 CASPubMed Google Scholar
Caver TE, Slobod KS, Flynn PM, Behm FG, Hudson MM, Turner EV, Webster RG, Boyett JM, Tassie TL, Pui CH, Hurwitz JL . Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia Leukemia 1998 12: 619–622 ArticleCAS Google Scholar
Pui CH, Rubnitz JE, Hancock ML, Downing JR, Raimondi SC, Rivera GK, Sandlund JT, Ribeiro RC, Head DR, Relling MW, Evans WE, Behm FG . Reappraisal of the clinical and biological significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia J Clin Oncol 1998 16: 3768–3773 ArticleCAS Google Scholar
Uckun FM, Sather HN, Gaynon PS, Arthur DC, Trigg ME, Tubergen DG, Nachman J, Steinherz PG, Sensel MG, Reaman GH . Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group Blood 1997 90: 28–35 CASPubMed Google Scholar
Babusikova O, Glasova M, Konikova E, Kusenda J, Cap J, Gyarfas J, Koubek K . Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia Neoplasma 1998 45: 128–134 CASPubMed Google Scholar
Boldt DH, Kopecky KJ, Head D, Gehly G, Radich JP, Appelbaum FR . Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience Leukemia 1994 8: 2118–2126 CASPubMed Google Scholar
Ryan D, Kossover S, Mitchell S, Frantz C, Hennessy L, Cohen H . Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens Blood 1986 68: 417–425 CASPubMed Google Scholar
Hurwitz CA, Loken MR, Graham ML, Karp JE, Borowitz MJ, Pullen DJ, Civin CI . Asynchronous antigen expression in B lineage acute lymphoblastic leukemia Blood 1998 72: 299–307 Google Scholar
Reading CL, Estey EH, Huh YO, Claxton DF, Sanchez G, Terstappen LW, O'Brien MC, Baron S, Deisseroth AB . Expression of unusual immunophenotype combinations in acute myelogenous leukemia Blood 1993 81: 3083–3090 CASPubMed Google Scholar
Terstappen LW, Safford M, Unterhalt M, Konemann S, Zurlutter K, Piechotka K, Drescher M, Aul C, Buchner T, Hiddemann W . Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells Leukemia 1992 6: 993–1000 CASPubMed Google Scholar
Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P, Gonzalez M, Bartram CR, Panzer-Grumayer ER, Biondi A, San Miguel JF, van Dongen JJ . Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia Leukemia 1999 13: 110–118 ArticleCAS Google Scholar